Back to homepage | Congress of the Month
Print view
 
 

Targeting Therapy of Alzheimer’s and Related Neurodegenerative Diseases

01.06.2018 - 04.06.2018

Melia Nassau Beach All Inclusive
Nassau W Bay Street
Nassau
Bahamas

Conference themes

Alzheimer’s disease (AD) is the most common age-dependent neurodegenerative disease, which affects over 5 million people in the US and over 35 million people worldwide.

Currently, only four drugs are approved for alleviating symptoms in AD patients, and no new therapy has been approved for AD since 2003.

Fees

Academic from: USD 1823.00
Industry from: USD 1823.00
Student from: USD 1534.00

Notes

Speakers: Riqiang Yan (Cleveland Clinic Lerner Research Institute), Peter St George-Hyslop (University of Toronto), Don Cleveland (University of California at San Diego), David Holtzman (Washington University) and many more.

Languages
Englisch
Enquiries and Registration

E-Mail: admin@fusion-conferences.com

Online Registration
 

 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

AGEM - Arbeitsgemeinschaft Ethnomedizin e. V.Anästhesie in Entwicklungsländern e. V.Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAMREF - African Medical and Research FoundationÄrzte der WeltFFG - 7. EU-RahmenprogrammÖsterreichische Gesellschaft für Public HealthHelix - Forschung & Beratung Wien

Facebook

Give us your professional opinion

Start survey

Start survey